These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7483508)

  • 1. [The prevalence of secondary resistance to peroral hypoglycemic agents among patients with type-2 diabetes mellitus].
    Gendeleka GF; Kuznetsova NP
    Lik Sprava; 1995; (1-2):103-5. PubMed ID: 7483508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Different clinical patterns of secondary drug failure in diabetes mellitus type II patients and their significance for diagnosis of secondary sulfonamide resistance].
    Gendeleka GF
    Lik Sprava; 2001; (3):158-9. PubMed ID: 11560011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An analysis of the causes of low-efficacy treatment in type-2 diabetes mellitus using sulfonylurea derivatives].
    Gendeleka GF
    Lik Sprava; 1996; (3-4):100-3. PubMed ID: 9035838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The peroral therapy of non-insulin-dependent diabetes mellitus].
    Ametov AS; Granovskaia-Tsvetkova AM
    Ter Arkh; 1994; 66(10):17-9. PubMed ID: 7863436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral antidiabetic agents: 2004.
    Lebovitz HE
    Med Clin North Am; 2004 Jul; 88(4):847-63, ix-x. PubMed ID: 15308382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical characteristics of patients with type-2 diabetes mellitus].
    Gendeleka GF; Lakiza VV; Perstnev AI
    Lik Sprava; 1996; (5-6):109-13. PubMed ID: 9377371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender risk of nonfatal stroke in type 2 diabetic patients differs depending on the type of treatment.
    Khalangot M; Hu G; Tronko M; Kravchenko V; Guryanov V
    J Womens Health (Larchmt); 2009; 18(1):97-103. PubMed ID: 19105694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
    Machoy M
    Ann Acad Med Stetin; 2004; 50(2):29-39. PubMed ID: 16529163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
    Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
    J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hypoglycemic drugs on aspirin resistance in patients with diabetes mellitus.
    Ariturk Z; Islamoglu Y; Gündüz E; Yavuz C; Cil H; Tekbas E; Soydinc S; Kaya H; Elbey MA
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):617-21. PubMed ID: 22774402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional differences in the prevalence of known Type 2 diabetes mellitus in 45-74 years old individuals: results from six population-based studies in Germany (DIAB-CORE Consortium).
    Schipf S; Werner A; Tamayo T; Holle R; Schunk M; Maier W; Meisinger C; Thorand B; Berger K; Mueller G; Moebus S; Bokhof B; Kluttig A; Greiser KH; Neuhauser H; Ellert U; Icks A; Rathmann W; Völzke H
    Diabet Med; 2012 Jul; 29(7):e88-95. PubMed ID: 22248078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes.
    Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
    Diabetes Res Clin Pract; 2008 Oct; 82(1):139-47. PubMed ID: 18703252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arfazetin in the treatment of diabetes mellitus].
    Korotkova VD; Perelygina AA; Trumpe TE; Sokolov SIa; Lobanova AM
    Probl Endokrinol (Mosk); 1988; 34(4):25-8. PubMed ID: 3057485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and related risk factors in type 2 diabetes mellitus.
    Lunetta M; Barbagallo A; Crimi S; Di Mauro M; Sangiorgio L; Mughini L
    Minerva Endocrinol; 1999 Jun; 24(2):45-50. PubMed ID: 10941422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria.
    Winkelmayer WC; Stedman MR; Pogantsch M; Wieninger P; Bucsics A; Asslaber M; Bauer R; Burkhardt T; Schautzer A; Brookhart MA;
    Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):57-65. PubMed ID: 21182153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inefficacy of oral antidiabetics: failure or natural history of diabetes?].
    Schönenweid C
    Rev Med Suisse Romande; 1995 Sep; 115(9):671-3. PubMed ID: 7481353
    [No Abstract]   [Full Text] [Related]  

  • 19. [The sulfanilamide resistance of patients with type-2 diabetes mellitus].
    Gendeleka GF; Lakiza VV
    Lik Sprava; 1993 Apr; (4):51-6. PubMed ID: 8209448
    [No Abstract]   [Full Text] [Related]  

  • 20. [Insulin monotherapy in patients with diabetes mellitus type 2 developing secondary resistance to sulfanilamide preparations].
    Gendeleka GF
    Lik Sprava; 2000 Mar; (2):72-4. PubMed ID: 10862482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.